Detailansicht

Wissensnetz

Person

Barbara Burwinkel (1969-)

Ärztin

Name	Barbara Burwinkel
Zeit	1969- (Lebensdaten)
Ort	Heidelberg (Wirkungsort) Deutschland
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Ärztin (charakteristischer Beruf)
Variante	B. Burwinkel
Beziehung	Frauenklinik (Heidelberg) (2008-)
Weitere Angaben	Diss. Fachbereich Humanmedizin
Datensatztyp	Person
GND-Nummer	120685760
Datensatz-ID	120685760
Beteiligt an alle anzeigen A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers Two truncating variants in FANCC and breast cancer risk Common variants in breast cancer risk loci predispose to distinct tumor subtypes Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer Cell-free DNA in breast cancer: a long way to go Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer Pathway analysis of genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a prospectively followed cohort of colorectal cancer patients miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome Blood-based DNA methylation as biomarker for breast cancer: a systematic review Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus Plasma S100P level as a novel prognostic marker of metastatic breast cancer Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry Genetic predisposition to ductal carcinoma in situ of the breast A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk Genetic predisposition to ductal carcinoma in situ of the breast Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer RAD51B in Familial Breast Cancer Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium Common germline polymorphisms associated with breast cancer-specific survival Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity Molekulargenetische Charakterisierung der genotypischen und phänotypischen Heterogenität von Leberglykogenosen durch Defekte im Phosphorylase-, Phosphorylase-Kinase-System

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Barbara Burwinkel (1969-)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Two truncating variants in FANCC and breast cancer risk

Common variants in breast cancer risk loci predispose to distinct tumor subtypes

Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis

A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study

Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

Cell-free DNA in breast cancer: a long way to go

Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer

Pathway analysis of genetic variants in folate-mediated one-carbon metabolism-related genes and survival in a prospectively followed cohort of colorectal cancer patients

miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome

Blood-based DNA methylation as biomarker for breast cancer: a systematic review

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Plasma S100P level as a novel prognostic marker of metastatic breast cancer

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

Genetic predisposition to ductal carcinoma in situ of the breast

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

Genetic predisposition to ductal carcinoma in situ of the breast

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

RAD51B in Familial Breast Cancer

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

Common germline polymorphisms associated with breast cancer-specific survival

Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity

Molekulargenetische Charakterisierung der genotypischen und phänotypischen Heterogenität von Leberglykogenosen durch Defekte im Phosphorylase-, Phosphorylase-Kinase-System